Low-tech, low-cost test strips show promise for reducing fentanyl overdoses

February 6, 2018 by Dori Henry, Johns Hopkins University Bloomberg School of Public Health

Fentanyl is one of the most potent forms of opioid, and is often laced into street drugs, making it difficult for street users to ascertain their potency and therefore the potential for overdosing.

A study to assess the feasibility of checking illicit street drugs for found that low-cost detect the presence of fentanyl with a high degree of accuracy, and that the vast majority of people who use are interested in using drug checking to help prevent overdoses.

The study, known as the FORECAST study, was conducted by researchers at the Johns Hopkins Bloomberg School of Public Health and Rhode Island Hospital/Brown University, with support from the Bloomberg American Health Initiative. The initial findings indicate that drug checking presents an opportunity for a approach to the fentanyl overdose crisis.

The results will be presented for discussion at a meeting with scientists and practitioners at Johns Hopkins Bloomberg School of Public Health on February 7, 2018 at 10:00 a.m. A webcast of the discussion will be available here.

In 2016, overdoses claimed more than 64,000 lives, and all indications are that the 2017 numbers will be even greater. Fentanyl, a synthetic opioid that is 50 to 100 times more potent than morphine, is the primary cause of the rapid increase in overdose deaths, and responsible for approximately 20,000 of the 2016 overdose deaths.

Fentanyl and its associated analogues have been found mixed with heroin and cocaine, and pressed into counterfeit prescription drugs.

"We are at a pivotal moment in the overdose epidemic, and we need to embrace the full range of interventions that can save lives," says Susan Sherman, Ph.D., MPH, professor in the Bloomberg School's Department of Health, Behavior and Society and study co-author. "Our findings bring to the table evidence that can inform a public health approach to the fentanyl crisis. Smart strategies that reduce harm can save lives."

Researchers conducted the study in three phases. The first phase assessed the ability of three drug checking technologies to detect the presence of fentanyl in street drug samples. In addition to the strip tests, the study assessed a TruNarc machine, which uses Raman spectroscopy, and a Bruker Alpha machine, which uses Fourier-transform infrared spectroscopy.

The technologies were tested in lab settings and compared to a gold standard for this type of testing, a Gas Chromatograph/Mass Spectrometer.

For each technology, the lab testing determined the lowest concentration (or percent amount for the Bruker Alpha) that could be detected (known as the detection limit), as well as the ability to detect fentanyl when it was present (sensitivity) and when it was not present (specificity) in street drug samples provided for this research study by the Baltimore and Providence Police Departments.

The test strips had the lowest detection limit and the highest rates of sensitivity and specificity. The TruNarc also had high rates of specificity, but low rates of sensitivity. The Bruker Alpha had high rates of both sensitivity and specificity, but lower than the test strips.

"The strips are appealing because they are so low threshold and have the highest sensitivity, specificity and level of detection," says Sherman. "However, I wouldn't rule out the Bruker, even though it is costlier. It would work best in a fixed site with a trained person to operate it."

The technologies were tested in lab settings and compared to a gold standard for this type of testing, a Gas Chromatograph/Mass Spectrometer. The BTNX fentanyl testing strips, which are based on an immunoassay to detect the presence or absence of fentanyl, were found to be the most accurate at detecting fentanyl.

In the study's second phase, researchers conducted anonymous surveys with 335 people who use drugs in Baltimore, Providence and Boston. In Baltimore, the researchers used drug arrest data to determine hotspots, and recruited participants in these areas from a mobile research van. In Providence and Boston, participants were recruited from syringe exchange and other harm reduction service provider locations.

The survey found that 84 percent of respondents were concerned that the drugs they use contain fentanyl, and only about one in four stated a preference for drugs with fentanyl. Drug checking was viewed as an important means of overdose prevention, with 89 percent agreeing that it would make them feel better about protecting themselves from overdose. Importantly, 70 percent of respondents reported that knowing that their drugs contained fentanyl would lead them to modify their behavior. This could include not using the drugs, using the drugs more slowly, using the drugs with others who have naloxone or changing their purchasing behaviors.

The study's third phase consisted of interviews with 32 key informants from organizations that work with people who use drugs to explore their interest in implementing drug checking services in their organization and potential barriers to doing so. Informants overwhelmingly support the concept of drug checking in order to provide people who use drugs with more information to keep themselves safe, and to provide another potential point of engagement to help those people access services. However, they also had questions related to the logistics and legality of implementing a checking program.

The study results are being released in advance of journal publication because of the urgency of the fentanyl overdose crisis.

Visit here for more information about the FORECAST study, and click here to view the results in greater detail.

Explore further: Fatal opioid overdoses on the rise in Canada

Related Stories

Fatal opioid overdoses on the rise in Canada

February 1, 2018
Fatal opioid overdoses jumped in Canada last year, especially in British Columbia, where the potent sedative fentanyl was detected in eight of 10 overdose deaths, according to preliminary figures released Wednesday.

Fighting overdose epidemic, US bans all fentanyl-type drugs

November 9, 2017
The US Justice Department on Thursday announced a ban on all fentanyl-like drugs amid skyrocketing rates of overdoses from the synthetic opioids.

Fentanyl in more than half of opioid deaths in 10 states

October 27, 2017
A federal report says the powerful painkiller fentanyl was involved in more than half of the recent opioid overdose deaths in 10 states.

Understanding pain exacerbation with opioid use

February 5, 2018
A new study published in JNeurosci advances understanding of how the potent opioid analgesic fentanyl can increase pain sensitivity in animals. These findings could inform the development of treatments for chronic pain that ...

Analyzing street drugs points to potential early warning system in opioid crisis

February 2, 2018
In just two years, the powerful opioid fentanyl went from nonexistent to detected in more than 1 in 7 stamp bags analyzed by the Allegheny County Office of the Medical Examiner, according to an analysis led by the University ...

US drug overdose deaths soar in 2016: report

June 6, 2017
US drug overdose deaths surged 19 percent to at least 59,000 last year as deadly manufactured drugs like fentanyl intensified a national opioid addiction crisis, New York Times data showed Tuesday.

Recommended for you

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

Less is more when it comes to prescription opioids for hospital patients, study finds

May 14, 2018
In a pilot study published in JAMA Internal Medicine, Yale researchers significantly reduced doses of opioid painkillers given to hospital patients. By delivering the opioids with a shot under the skin or with a pill instead ...

Generic options provide limited savings for expensive drugs

May 7, 2018
Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released today in its May issue.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.